A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment

Impact of leukocytosis on thrombotic risk and survival in 532 patients with essential thrombocythemia: a retrospective study

(2011) Francesca Palandri et al.   ANNALS OF HEMATOLOGY

Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification

(2011) J. Thiele et al.   BLOOD

Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients

(2011) A. Carobbio et al.   BLOOD

Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

(2011) Tiziano Barbui et al.   JOURNAL OF CLINICAL ONCOLOGY

Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study

(2011) Tiziano Barbui et al.   JOURNAL OF CLINICAL ONCOLOGY

Leukocytosis is associated with poor survival but not with increased risk of thrombosis in essential thrombocythemia: a population-based study of 311 patients

(2010) F Girodon et al.   LEUKEMIA

Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients

(2010) D Caramazza et al.   LEUKEMIA

Correlation between leukocytosis and thrombosis in Philadelphia-negative chronic myeloproliferative neoplasms

(2009) Domenica Caramazza et al.   ANNALS OF HEMATOLOGY

Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low-risk essential thrombocythemia and polycythemia vera

(2009) Naseema Gangat et al.   CANCER

Significant increase in the apparent incidence of essential thrombocythemia related to new WHO diagnostic criteria: a population-based study

(2009) F. Girodon et al.   HAEMATOLOGICA

Increase in leukocyte count over time predicts thrombosis in patients with low-risk essential thrombocythemia

(2009) F. PASSAMONTI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: A systematic review

(2009) Federico Lussana et al.   THROMBOSIS RESEARCH

Thrombocytosis and leukocytosis interaction in vascular complications of essential thrombocythemia

(2008) A. Carobbio et al.   BLOOD

Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients

(2008) F. Passamonti et al.   HAEMATOLOGICA

Leukocytosis and Risk Stratification Assessment in Essential Thrombocythemia

(2008) Alessandra Carobbio et al.   JOURNAL OF CLINICAL ONCOLOGY

Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders

(2008) F Cervantes et al.   LEUKEMIA

Is JAK2 V617F mutation more than a diagnostic index?

(2008) Issa J. Dahabreh et al.   LEUKEMIA RESEARCH